Men with retinitis pigmentosa should use Avana 200 mg with caution and under the supervision of a healthcare professional. Retinitis pigmentosa is a genetic eye disorder that causes progressive vision loss due to the degeneration of cells in the retina.
Avanafil, the active ingredient in
Avana 200mg, belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors, which are used to treat erectile dysfunction (ED). These medications have been associated with rare cases of visual disturbances, including changes in color vision and blurred vision. While these side effects are uncommon, individuals with pre-existing eye conditions such as retinitis pigmentosa may be at higher risk.
Before using Avana 200 mg or any medication for ED, individuals with retinitis pigmentosa should consult with an ophthalmologist or healthcare provider who is familiar with their medical history. They can assess the potential risks and benefits of using Avana 200 mg and provide personalized recommendations based on individual circumstances.
It's essential to be vigilant for any changes in vision while taking Avana 200 mg and to promptly report any concerns to a healthcare provider. If sudden vision loss or other serious visual disturbances occur, medical attention should be sought immediately.
Overall, the safety of Avana 200 mg in individuals with retinitis pigmentosa has not been extensively studied, so caution is warranted. Open communication with a healthcare provider is crucial to ensure safe and appropriate treatment for erectile dysfunction while considering any potential risks to vision health.
Logga in
Bli medlem
FAQ
Sök
